glp-1 receptor agonist market Size, Trends and Share Report 2026 GLP-1 Agonists Market Report 2025-2033,

Are you a candidate?

Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.

Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors

Each vial contains 10mg of lyophilized Tirzepatide, manufactured under strict laboratory protocols in the United States

95% CI 0.97, 1.15)

While these agents are not recommended during pregnancy, their use in the preconception, periconception, and postpartum periods is increasing